Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Eradication of asymptomatic bacteriuria to prevent early periprosthetic infection after hip hemiarthroplasty
2016-001108-47Phase 4Completed
- Sponsor
- Vall d'Hebron Research Institute
- Start
- Apr 2016
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, single-arm trial of fosfomycin in Periprosthetic Hip Infection (PHI) and asymptomatic bacteriuria (ASB), sponsored by Vall d'Hebron Research Institute. Primary endpoint: Cumulative incidence of early periprosthetic infection. Started Apr 2016; status: completed.
02
Drugs
fosfomycin
03
Conditions
Periprosthetic Hip Infection (PHI)asymptomatic bacteriuria (ASB)
Beyond the preview
Go deeper on 2016-001108-47.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2016-001108-47.